Evidence map›Paper›PMID 27294619›Full record

ArticleNature genetics2016

Protein-structure-guided discovery of functional mutations across 19 cancer types.

Beifang Niu, Adam D Scott, Sohini Sengupta, Matthew H Bailey, Prag Batra, Jie Ning, Matthew A Wyczalkowski, Wen-Wei Liang, Qunyuan Zhang, Michael D McLellan and 9 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 150 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. International journal of molecular sciences · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Beifang NiuMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.
Adam D ScottMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.
Sohini SenguptaMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.
Matthew H BaileyMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.
Prag BatraMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.
Jie NingMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.
Matthew A WyczalkowskiMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.ORCID 0000-0003-4197-551X
Wen-Wei LiangMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.
Qunyuan ZhangMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.
Michael D McLellanMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.
Sam Q SunMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.
Piyush TripathiDivision of Nephrology, Department of Medicine, Washington University, St. Louis, Missouri, USA.
Carolyn LouMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.
Kai YeMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.
R Jay MashlMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.
John WallisMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.
Michael C WendlMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.
Feng ChenDivision of Nephrology, Department of Medicine, Washington University, St. Louis, Missouri, USA.
Li DingMcDonnell Genome Institute, Washington University, St. Louis, Missouri, USA.ORCID 0000-0003-1517-2975
James S. McDonnell Foundation · USWashington University in St. Louis · US

Funding

A Turnkey System for High-throughput Variant Discovery and InterpretationU01HG006517 · NHGRI · WASHINGTON UNIVERSITY · PI DING, LI · 2012 to 2015
$3.0M
NFAT SIGNALING IN GLOMERULOSCLEROSISR01DK087960 · NIDDK · WASHINGTON UNIVERSITY · PI CHEN, FENG · 2010 to 2014
$1.6M
CANCER SUSCEPTIBILITY VARIANT DISCOVERY IN HIGH THROUGHPUT SEQUENCING DATAR01CA180006 · NCI · WASHINGTON UNIVERSITY · PI DING, LI · 2013 to 2016
$1.1M
VIRUS DISCOVERY AND CHARACTERIZATION IN LARGE-SCALE CANCER SEQUENCING DATAR01CA178383 · NCI · WASHINGTON UNIVERSITY · PI DING, LI · 2014 to 2016
$772k
NCI NIH HHS R01 CA178383NCI NIH HHS R01 CA180006NHGRI NIH HHS U01 HG006517NIDDK NIH HHS R01 DK087960
6 · The paper itself

Abstract

Local concentrations of mutations are well known in human cancers. However, their three-dimensional spatial relationships in the encoded protein have yet to be systematically explored. We developed a computational tool, HotSpot3D, to identify such spatial hotspots (clusters) and to interpret the potential function of variants within them. We applied HotSpot3D to >4,400 TCGA tumors across 19 cancer types, discovering >6,000 intra- and intermolecular clusters, some of which showed tumor and/or tissue specificity. In addition, we identified 369 rare mutations in genes including TP53, PTEN, VHL, EGFR, and FBXW7 and 99 medium-recurrence mutations in genes such as RUNX1, MTOR, CA3, PI3, and PTPN11, all mapping within clusters having potential functional implications. As a proof of concept, we validated our predictions in EGFR using high-throughput phosphorylation data and cell-line-based experimental evaluation. Finally, mutation-drug cluster and network analysis predicted over 800 promising candidates for druggable mutations, raising new possibilities for designing personalized treatments for patients carrying specific mutations.

Indexed as

AlgorithmsAntineoplastic AgentsComputational BiologyDatabases, PharmaceuticalDatabases, ProteinGene Expression Regulation, NeoplasticHumansModels, MolecularMutationNeoplasm ProteinsNeoplasmsProtein BindingProtein Interaction MapsProtein Structure, TertiaryAntineoplastic AgentsNeoplasm Proteins

Identifiers

PMID27294619
PMCPMC5315576
OpenAlexW2439991713

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.